BIOEPCIN Trademark

Trademark Overview

On Tuesday, March 28, 2023, a trademark application was filed for BIOEPCIN with the United States Patent and Trademark Office. The USPTO has given the BIOEPCIN trademark a serial number of 97860018. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, September 3, 2024. This trademark is owned by Biocon Limited. The BIOEPCIN trademark is filed in the Medical Instrument Products category with the following description:

Medical fluid injectors
bioepcin

General Information

Serial Number97860018
Word MarkBIOEPCIN
Filing DateTuesday, March 28, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements

Goods and ServicesMedical fluid injectors

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, April 19, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiocon Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKarnataka 560100
IN
Party NameBiocon Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKarnataka 560100
IN

Trademark Events

Event DateEvent Description
Friday, September 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 31, 2023NEW APPLICATION ENTERED
Wednesday, April 19, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 20, 2023ASSIGNED TO EXAMINER
Friday, September 29, 2023NON-FINAL ACTION WRITTEN
Friday, September 29, 2023NON-FINAL ACTION E-MAILED
Friday, September 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 29, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 6, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, November 6, 2023EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2023EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2023EXAMINER'S AMENDMENT ENTERED
Monday, November 6, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, November 6, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2023EXAMINER'S AMENDMENT ENTERED
Monday, December 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024SOU EXTENSION 1 FILED
Tuesday, September 3, 2024SOU EXTENSION 1 GRANTED
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

bioepcin injectors fluid medical